Preview

Вестник хирургии имени И.И. Грекова

Расширенный поиск

ВОЗМОЖНОСТИ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА 2-го ТИПА

https://doi.org/10.24884/0042-4625-2013-172-1-111-115

Полный текст:

Об авторах

Михаил Борисович Фишман
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Мария Олеговна Соловьёва
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Сергей Петрович Мужиков
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Павел Евгеньевич Куприн
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Ма Чие
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова
Россия


Список литературы

1. Консенсус Российских экспертов по проблеме метаболического синдрома в Российской Федерации: определение, диагностические критерии, первичная профилактика и лечение // Рациональная фармакотерапия в кардиологии. 2010. № 4. С. 599–606.

2. Brolin R. E., LaMarca L. B., Kenler H. A. Malabsorptive gastric bypass in patients with superobesity // J Gastrointest Surg. 2002. Vol. 6. P. 195–205.

3. Buchwald H., Avidor Y., Braunwald E. Bariatric surgery: a systematic review and meta-analysis // JAMA. 2004. Vol. 292. P. 1724– 1737.

4. Buchwald H., Estok R., Fahrbagh K. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis // Amer. J. Med. 2009. Vol. 486. P. 1426–1439.

5. Bittner R., Bittner B., Beger H. G. Homeostasis of glucose and gastric resection: the influence of the food passage through the duodenum // Z Gastroenterol. 1981. Vol. 19. P. 698–707.

6. Camus J. P. Gout, diabetes, hyperlipemia: a metabolic trisyndrome // Rev. Rhum. Mal. Osteoartic. 1966. Vol. 33, № 1. P. 10–14.

7. Cavaghan M. K., Ehrmann D. A., Polonsky K. S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance // J. Clin. Invest. 2000. Vol. 106. P. 529–533.

8. Cohen R. V., Schiavon C. A., Pinheiro J. S. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–54 kg/m2: a report of 2 cases // Surg. Obes. Relat. Dis. 2007. Vol. 3, № 2. P. 195–197.

9. Cowan G. S., Buffington C. K. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery // Word J. Surg. 1998. Vol. 22. P. 987–992.

10. Cummings D. E., Overduin J., Foster-Schuhert K. E. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution // J. Clin. Endocrinol. Metab. 2004. Vol. 89. P. 2608–2315.

11. Cummings D. E., Overduin J., Foster-Schubert K. E. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery // Surg. Obes. Relat. Dis. 2007. Vol. 3, № 2. P. 109–115.

12. Cummings D. E., Weigle D. S., Frayo R. S. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery // N. Engl. J. Med. 2002. Vol. 346. P. 1623–1630.

13. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes // Endocr. Rev. 2002. Vol. 23. P. 599–622.

14. Faraj M., Jones P., Sniderman A. D. Enhanced dietary fat clearance in postobese women // J. Lipid. Res. 2001. Vol. 42. P. 571–580.

15. Foley E. F., Benotti P. N., Borlase B. C. Impact of gastric restrictive surgery on hypertension in the morbidly obese // Am. J. Surg. 1992. Vol. 163. P. 294–297.

16. Friedman N. M., Sancetta A. J., Magovern G. J. The amelioration of diabetes mellitus following subtotal gastrectomy // Surg. Gynecol. Obstetr. 1955. Vol. 100. P. 201–204.

17. Holdstok C., Engstrom B. E., Ohrvall M. J. Ghrelin and adipose tissue regulatory peptides: effects of gastric bypass surgery on obese humans // Clin. Endocrinol. Metab. 2003. Vol. 88. P. 3177–3183.

18. Korner J., Bessler M., Cirilo L. J. Effects of Roux-en — Y gastric bypass surgery on fasting and pastprandial concentrations of plasma ghrelin, peptide YY, and insulin // J. Clin. Endocrinol. Metab. 2005. Vol. 90. P. 359–165.

19. Le Roux C. W., Aylwin S. J., Baiterham R. L. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters // Ann. Surg. 2006. Vol. 243. P. 108–114.

20. Lewis G. F., Carpentier A., Adeli K., Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes // Endocr. Rev. 2002. Vol. 23. P. 201–229.

21. Lima J., Helena L., Oliveira S. Rapid resolution of diabetes after gastric bypass // Obes. Surg. 2005. Vol. 15. P. 448–449.

22. MacDonald K. G., Long S. D., Swanson M. S. The gastric bypass operation reduces the progression and mortality of non-insulindependent diabetes mellitus // J. Gastrointest. Surg. 1997. Vol. 1. P. 213–220.

23. MacLean L. D., Rhode B. M., Nohr C. W. Long-or short-limb gastric bypass? // J. Gastrointest. Surg. 2001. Vol. 5. P. 525–530.

24. Mahler R. J., Adler M. L. Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment // J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 1165–1171.

25. Mason E. E. Ileal transposition and enteroglucagim/GLP1 in obesity (and diabetic?) surgery // Obes. Surg. 1999. Vol. 9. P. 223–228.

26. Mason E. E. The mechanism of surgical treatment of type 2 diabetes // Obes. Surg. 2005. Vol. 15. P. 459–461.

27. Mingrone G., De Gaetano A., Greco A. V. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids // Diabetologia. 1997. Vol. 40. P. 599–605.

28. Naslund E., Grybagk P., Hellstrom P. M. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity // Int. J. Obes. Relat. Metab. Disord. 1997. Vol. 21. P. 387–392.

29. Noya G., Cossu M.L, Coppola M. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type 2: results in the first 10 cases // Obes. Surg. 1998. Vol. 8. P. 67–72.

30. Patriti A., Facchiano E., Sanna A. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery // Obes. Surg. 2004. Vol. 14. P. 840–848.

31. Ponce J., Haynes B., Paynter S. Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension // Obes. Surg. 2004. Vol. 14. P. 1335–1342.

32. Pories W. J. Diabetes: the evolution of a new paradigm // Ann. Surg. 2004. Vol. 2.39. P. 12–13.

33. Pories W. J., Albrccht R. J. Etiology of type II diabetes mellitus: role of the foregut // World J. Surg. 2001. Vol. 25. P. 527–531.

34. Pories W. J., MacDonald K. G., Morgan E. J. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up // Am J. Clin. Nutr. 1992. Vol. 55 (2 Suppl.). P. 582S–585S.

35. Pories W. J., Swanson M. S., MacDonald K. G. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus // Ann. Surg. 1995. Vol. 222. P. 339–350.

36. Rubino F., Forgione A., Cummings D. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes // Ann. Surg. 2006. Vol. 244, № 5. P. 741–749.

37. Rubino F., Gagner M. Potential of surgery for curing type 2 diabetes mellitus // Ann. Surg. 2002. Vol. 236. P. 554–559.

38. Rubino F., Gagner M., Gentileschi P. The early effect of the Roux-en-Y gastric, bypass on hormones involved in body weight regulation and glucose, metabolism // Ann. Surg. 2004. Vol. 240. P. 236–242.

39. Rubino F., Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective, for an old disease // Ann. Surg. 2004. Vol. 239. P. 1–11.

40. Schauer P. R., Burcuera B., Ikramuddin S. Effect of laparoscopic Roux-en Ygastric bypass on type 2 diabetes mellitus // Ann. Surg. 2003. Vol. 238. P. 467–484.

41. Schauer P. R., Ikramuddin S., Gourash W. Outcomes after laparoscopic roux-en-Y gastric bypass for morbid obesity // Ann. Surg. 2000. Vol. 232. P. 515–529.

42. Scopinaro N., Adami G. F., Marinari G. M. Biliopancreatic diversion // World J. Surg. 1998. Vol. 22. P. 936–946.

43. Scopinaro N., Marinari G. M., Camerini G. B. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a longterm follow-up study // Diabetes Care. 2005. Vol. 28. P. 2406–2411.

44. Sjostrom L., Lindroos A. K., Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery // N. Engl. J. Med. 2004. Vol. 351. P. 2683–2693.

45. Smith S., Enwards C. B., Goodman G. N. Changes in diabetic management after Roux en-Y gastric bypass // Obes. Surg. 1996. Vol. 6. P. 345–348.

46. World Diabetes Day. United Nations Resolution, General Assembly 61/225.18 Jan 2007.


Для цитирования:


Фишман М.Б., Соловьёва М.О., Мужиков С.П., Куприн П.Е., Чие М. ВОЗМОЖНОСТИ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА 2-го ТИПА. Вестник хирургии имени И.И. Грекова. 2013;172(1):111-115. https://doi.org/10.24884/0042-4625-2013-172-1-111-115

Просмотров: 62


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0042-4625 (Print)
ISSN 2686-7370 (Online)